Near-instantaneous, quality-reviewed case availability would shift signal detection from periodic retrospection to continuous operations, materially accelerating expedited reporting and downstream ...

The European Medicines Agency (EMA) on Wednesday touted the results of a six-year review that show improvements to signal management for medicines within the EU following pharmacovigilance reforms in ...

Veeva Vault Signal will accelerate signal management processes from detection through risk evaluation and mitigation “Veeva Vault Signal is welcome news for companies looking for an efficient, ...

The main market opportunities in this course involve professionals needing to understand EU Regulation on Veterinary Medicinal Products, particularly those affected by the upcoming 2024 amendments. It ...

The European Medicines Agency (EMA) has released a new set of recommendations for postmarket surveillance for veterinary medicinal products, which will go into effect on 1 October 2015.

Embrace cloud, AI, and interoperability in pharmacovigilance software to meet stricter global compliance, improve safety data management, and support unified safety operations amidst rising data ...

WALTHAM, Mass., Jan 21, 2010 (BUSINESS WIRE) -- Phase Forward (NASDAQ: PFWD), a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 ...

DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance World 2025" conference has been added to ResearchAndMarkets.com's offering. As medical science advances, so does our understanding of drug safety and ...

The FDA Guidance to Industry on Good Pharmacovigilance Practices1 was issued in March. This guidance applies to drugs, including biological products (excluding blood components), and is provided to ...

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) today announced Veeva Vault Signal, the industry’s first solution that seamlessly manages signals from identification through risk ...